Perspective – New Drugs: Where Did We Go Wrong and What Can We do Better?

New drugs: where did we go wrong and what can we do better? – The BMJ (free)

Commentary: No evidence of added benefit for most new drugs entering German healthcare system – The BMJ (free)

Related Commentary on Twitter

More than half of new drugs in Germany lack proof of added benefit over existing treatments. International drug development processes and policies are responsible and must be reformed, says this #BMJAnalysis https://t.co/Yx9WAWjaTC

— The BMJ (@bmj_latest) July 11, 2019